Sodium dodecyl sulfate

CAS No. 151-21-3

Sodium dodecyl sulfate( —— )

Catalog No. M33654 CAS No. 151-21-3

Sodium dodecyl sulfate(Sodium lauryl sulfate) is a pharmaceutical excipient that is biologically inactive and improves the stability, solubility and processability of pharmaceutical preparations.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Sodium dodecyl sulfate
  • Note
    Research use only, not for human use.
  • Brief Description
    Sodium dodecyl sulfate(Sodium lauryl sulfate) is a pharmaceutical excipient that is biologically inactive and improves the stability, solubility and processability of pharmaceutical preparations.
  • Description
    Sodium dodecyl sulfate for Electrophoresis,≥98.5% is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    151-21-3
  • Formula Weight
    288.38
  • Molecular Formula
    C12H25NaO4S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 250 mg/mL (866.91 mM; Ultrasonic )H2O : 100 mg/mL (346.76 mM; Ultrasonic)
  • SMILES
    O=S([O-])(OCCCCCCCCCCCC)=O.[Na+]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • N-Methyldehydrococla...

    N-Methyldehydrococlaurine

  • Abrucomstat

    Abrucomstat (3-NOP) (3-Nitroxypropanol) functions as an enzyme inhibitor, effectively reducing ruminal methanogenesis.

  • Etifoxine hydrochlor...

    Etifoxine is an anxiolytic and anticonvulsant drug.?Unlike benzodiazepines, etifoxine appears to produce its anxiolytic effects by binding to β2 and β3 subunits of the GABAA receptor complex, and so is acting at a different target site to benzodiazepines, although the physiological effect that is produced is similar to that of benzodiazepines.